One of the fundamental barriers to equitable neurological care is the historic male bias in clinical research. For decades, ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

After witnessing my mum's cognitive decline and with dementia now the leading cause of death for Australian women, I can't ...

Have you or someone you love been diagnosed with Alzheimer’s disease? This clinical trial may be just what you.

A recent population-based study published in the Journal of American Medical Association identified a modest increase in ...

A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.

Two new studies have provided further insights into the complex links between head injury in elite rugby and potential ...

Measuring insulin resistance with a simple, low-cost blood test can help predict the pace of cognitive decline in patients ...

The team used a special type of brain scan called tau PET, which tracks a protein known as tau that builds up in the brain ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

As new treatments emerge, timely diagnosis helps match patients with the most appropriate care when it can have the greatest ...

The overall market for frontotemporal dementia is expected to grow with the anticipated launch of emerging therapies, including Latozinemab, PBFT02, ...